Ticagrelor and the Risk of In-Hospital Gout
International Heart Journal · 2025
DOI: 10.1536/ihj.24-306 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Heart Journal, 2025. Verfasst von Hong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Dali University. Hauptthemen laut MEDLINE: Ticagrelor, Gout, Acute Coronary Syndrome, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Dali University.
- Yunnan Trans-plateau Cardiovascular Disease of Prevention and Treatment Research Center.
Zitieren
APA
Liu, H., Jiangxue, G., Dong, Y., Yang, Y., Yang, X., Sun, B., Ma, L., Li, T., & Wu, X. H. (2025). Ticagrelor and the Risk of In-Hospital Gout. International Heart Journal. https://doi.org/10.1536/ihj.24-306
Vancouver
Liu H, Jiangxue G, Dong Y, Yang Y, Yang X, Sun B, et al. Ticagrelor and the Risk of In-Hospital Gout. International Heart Journal. 2025. doi:10.1536/ihj.24-306
BibTeX
@article{Liu2025,
author = {Liu, Hong and Jiangxue, Guo and Dong, Yu and Yang, Ying and Yang, Xitong and Sun, Biao and Ma, Lilan and Li, Tao and Wu, Xin-Hua},
title = {Ticagrelor and the Risk of In-Hospital Gout},
journal = {International Heart Journal},
year = {2025},
doi = {10.1536/ihj.24-306}
}
EUVIMED